| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.decipherlabs.in | |
| Market Cap | 21.31 Cr. | |
| Enterprise Value(EV) | 24.76 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 16.17 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 1.31 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 32.80 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 32.53 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 0.65 | Calculated using Price: 21.10 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.01 Cr. | 10,100,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Combat is a professionally managed, well established public limited company, engaged in the manufacture & marketing of Pharmaceutical Formulations since its incorporation in 1986. The company has been marketing its branded formulations and entering into agreements with various companies for custom manufacturing and has grown to be known as a quality provider. | ||
| 1 Day |
|
-4.74% |
| 1 Week |
|
-19.16% |
| 1 Month |
|
-30.25% |
| 3 Month |
|
-30.82% |
| 6 Month |
|
-47.32% |
| 1 Year |
|
-70.98% |
| 2 Year |
|
-43.13% |
| 5 Year |
|
-22.99% |
| 10 Year |
|
-76.56% |
| 5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 8.60 | 17.45 | 14.59 | 10.69 | 60.15 | |
| Return on Capital Employed (%) | 8.10 | 17.95 | 18.11 | 13.09 | 40.71 | |
| Return on Assets (%) | 6.16 | 8.71 | 5.28 | 3.79 | 28.24 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 2 | 3 | 13 | 14 | 24 | 33 | |
| Non Curr. Liab. | 1 | 8 | 7 | 0 | |||
| Curr. Liab. | 1 | 4 | 21 | 17 | 11 | 9 | |
| Minority Int. | |||||||
| Equity & Liab. | 3 | 6 | 35 | 39 | 42 | 42 | |
| Non Curr. Assets | 0 | 13 | 16 | 4 | 6 | ||
| Curr. Assets | 3 | 6 | 23 | 23 | 38 | 36 | |
| Misc. Exp. not W/O | |||||||
| Total Assets | 3 | 6 | 35 | 39 | 42 | 42 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 1 | 8 | 24 | 56 | 65 | 62 | |
| Other Income | 0 | 0 | 1 | 8 | 17 | ||
| Total Income | 1 | 8 | 24 | 56 | 73 | 79 | |
| Total Expenditure | -1 | -8 | -21 | -52 | -59 | -60 | |
| PBIDT | 0 | 0 | 3 | 4 | 14 | 19 | |
| Interest | 0 | -1 | -1 | 0 | -1 | ||
| Depreciation | -1 | -1 | -1 | -1 | |||
| Taxation | 0 | 0 | -1 | -1 | -1 | ||
| Exceptional Items | |||||||
| PAT | 0 | 0 | 1 | 1 | 11 | 16 | |
| Minority Interest | |||||||
| Share Associate | |||||||
| Other Related Items | |||||||
| Consolidated Net Profit | 0 | 0 | 1 | 1 | 11 | 16 | |
| Adjusted EPS | 0 | 1 | 1 | 1 | 11 | 16 |
| Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | -15 | 2 | 8 | |
| Cash Fr. Inv. | 0 | 0 | 0 | 0 | ||
| Cash Fr. Finan. | 0 | 0 | 16 | 4 | 1 | |
| Net Change | 0 | 0 | 1 | 6 | 9 | |
| Cash & Cash Eqvt | 0 | 0 | 1 | 7 | 15 |
|
Tue, 07 Feb 2023
Board Meeting Intimation for Un-Audited Financial Results Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Un-audited financial results the quarter ended 31.12.2022. |
|
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations 2018 |
|
Tue, 27 Dec 2022
Closure of Trading Window Closure of trading window |
| Tue, 07 Feb 2023 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Opening at High
|
Making Lower Lows for 3 days
|
Equities
M.F.
Sectors